Hypersensitivity reaction to a biosimilar insulin glargine 对甘精胰岛素生物仿制品的过敏反应-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypersensitivity reaction to a biosimilar insulin glargine 对甘精胰岛素生物仿制品的过敏反应

Published:2015-01-07 Issue:2 Volume:7 Page:155-157
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

García-Nares Héctor¹,Leyva-Carmona María Isabel²,Pérez-Xochipa Neftalí¹,Chiquete Erwin³

Affiliation:

1. Department of Endocrinology; Regional Hospital 1st of October; ISSSTE; México, DF México

2. Department of Immunology; Regional Hospital 1st of October; ISSSTE; México, DF México

3. Department of Neurology; The “Salvador Zubirán” National Institute of Medical Sciences and Nutrition; México, DF México

Funder

Sanofi Mexico

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Reference10 articles.

1. Glargine insulin is not an alternative in insulin allergy;Durand-Gonzalez;Diabetes Care,2003

2. The human insulin analog aspart can induce insulin allergy;JiXiong;Diabetes Care,2004

3. Systemic allergic reaction by a human insulin analog;Barranco;Allergy,2003

4. Systemic allergy to human insulin and its rapid and long acting analogs: Successful treatment by continuous subcutaneous insulin lispro infusion;Castéra;Diabetes Metab,2005

5. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine;Wu;Ann Endocrinol (Paris),2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilar insulin concepts;Journal of Diabetes;2022-03-28

2. Decision Support Systems and Closed-Loop;Diabetes Technology & Therapeutics;2021-06-01

3. New Insulins, Biosimilars, and Insulin Therapy;Diabetes Technology & Therapeutics;2021-06-01

4. Formulary Considerations for Insulins Approved Through the 505(b)(2) “Follow-on” Pathway;Annals of Pharmacotherapy;2018-08-20

5. Evaluation of the innate immunostimulatory potential of originator and non-originator copies of insulin glargine in an in vitro human immune model;PLOS ONE;2018-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3